Compare iShares 7-10 Year Treasury Bond ETF (IEF) vs Immunovant Inc. Common Stock (IMVT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares 7-10 Year Treasury Bond ETF vs Immunovant Inc. Common Stock — how do they compare? iShares 7-10 Year Treasury Bond ETF trades at $89.35 (market cap $41.13B), while Immunovant Inc. Common Stock trades at $30.49 (market cap $6.25B). The key difference: iShares 7-10 Year Treasury Bond ETF is far larger — about 6.6× Immunovant Inc. Common Stock's market cap, and Immunovant Inc. Common Stock is trading nearer its 52-week high, iShares 7-10 Year Treasury Bond ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares 7-10 Year Treasury Bond ETF for 108 Days and Immunovant Inc. Common Stock for 0 Days on average.
| IEF | IMVT | |
|---|---|---|
Market Cap | $41.13B | $6.25B |
Volume | 10,340,382 | 1,755,411 |
Sector | Fixed Income | Health |
52-Week High | $97.99 | $44.96 |
52-Week Low | $88.92 | $17.03 |
Typical Hold Time | 108 Days | 0 Days |
Enterprise Value | — | $5.35B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IEF trades at $89.295 with a modest 0.21% daily gain amid a challenging bond market environment. Technical indicators show a bearish trend with moving averages signaling sell pressure, though oscillators remain neutral. Recent Treasury yield volatility and bond market selloffs have created headwinds for fixed income ETFs, while dividend distributions continue with recent payouts around $0.31-0.33 per share.
The outlook remains cautious as rising Treasury yields and inflation concerns pressure bond ETFs. While current yields provide income appeal, further rate increases could depress prices. Investors face the trade-off between defensive positioning and potential capital depreciation if the bond rout continues.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares 7-10 Year Treasury Bond ETF
The underlying index measures the performance of public obligations of the US Treasury that have a remaining maturity of greater than or equal to seven years and less than ten years. The fund will invest at least 80% of its assets in the component securities of the underlying index, and the fund will invest at least 90% of its assets in US Treasury securities that the advisor believes will help the fund track the underlying index.
Read more on IEF →About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →
